Oruka Therapeutics, Inc. Common Stock (ORKA) is a publicly traded Healthcare sector company. As of October 21, 2026, ORKA trades at $79.11 with a market cap of $4.93B and a P/E ratio of 0.00. ORKA moved +6.26% today. Year to date, ORKA is +179.77%; over the trailing twelve months it is +187.81%. Its 52-week range spans $5.49 to $115.52. Analyst consensus is strong buy with an average price target of $154.50. Rallies surfaces ORKA's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies AI research for ORKA combines live market data, fundamentals, news, analyst context, hedge fund holdings, politician trades, insider activity, and risk factors into a ticker-specific research workflow.
| Metric | Value |
|---|---|
| Price | $79.11 |
| Market Cap | $4.93B |
| P/E Ratio | 0.00 |
| EPS | $0.00 |
| Dividend Yield | 0.00% |
| 52-Week High | $115.52 |
| 52-Week Low | $5.49 |
| Volume | 672.97K |
| Avg Volume | 0 |
| Revenue (TTM) | $0 |
| Net Income | $-105.43M |
| Gross Margin | 0.00% |
11 analysts cover ORKA: 0 strong buy, 11 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $154.50.